Medley Pharmaceuticals

Industry

  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
See more in Biomedtracker

Latest on Medley Pharmaceuticals

Pink Sheet

Asia Spotlight: Emerging Markets At Stake As Viehbacher Departs Sanofi?

 
• By Brian Yang

On the second Monday of each month, “The Pink Sheet” provides exclusive news and commentary on the Asia biopharma market from the editors of our affiliated publication PharmAsia News. BEIJING – O

Scrip

Emerging Markets At Stake As Viehbacher Departs Sanofi?

 
• By Brian Yang

BEIJING – On Sept. 26, former Sanofi chief executive Chris Viehbacher landed in China’s capital, leading the first-ever EFPIA delegation to the Middle Kingdom. In his opening remarks, Viehbacher p

Scrip

India’s Intas Under Vietnamese Regulatory Lens?

 
• By Vikas Dandekar

MUMBAI - The Drug Administration of Vietnam has reportedly launched a probe against India’s Intas Pharmaceuticals Ltd. on alleged charges of supplying low quality products. A detailed government d

Scrip

Novo Struggles In Japan, Sanofi Struggles With Distributors: Emerging Markets Earnings Roundup (Part 7)

 
• By Brian Yang

In a recurring feature, PharmAsia News combs through quarterly earnings reports to bring you highlights on Asia and emerging markets. In the last installment, PharmAsia News looked at the emerging mar